900000000000526001: REPLACED BY association reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Association type\Historical association reference set (foundation metadata concept)\REPLACED BY association reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
REPLACED BY association reference set (foundation metadata concept)	Is a	Historical association reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	targetComponentId
Long-acting thyroid stimulator	Thyroid stimulating immunoglobulins
Loperamide 2mg oral lyophilisate tablet	Loperamide hydrochloride 2 mg oral tablet
Loperamide hydrochloride 1mg/5mL conventional release oral syrup	Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug)
Loperamide hydrochloride 1mg/5mL sugar free syrup	Product containing precisely loperamide hydrochloride 200 microgram/1 milliliter conventional release oral solution (clinical drug)
Loperamide hydrochloride 2mg orodispersible tablet	Loperamide hydrochloride 2 mg oral tablet
Loperamide hydrochloride+simethicone	Product containing loperamide and simeticone (medicinal product)
Lophortyx gambelii	Callipepla gambelii (organism)
Loracarbef 100mg/5mL oral suspension	Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Loracarbef 100mg/5mL suspension	Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Loracarbef 200mg/5mL oral suspension	Loracarbef 40 mg/mL oral suspension
Loracarbef 200mg/5mL suspension	Loracarbef 40 mg/mL oral suspension
Loracarbef, anhydrous 100mg/5mL powder	Product containing precisely loracarbef 20 milligram/1 milliliter conventional release oral suspension (clinical drug)
Loracarbef, anhydrous 200mg/5 mL powder	Loracarbef 40 mg/mL oral suspension
Loratadine 10mg/10mL syrup	Loratadine 1 mg/mL oral solution
Loratadine+pseudoephedrine sulfate 5mg/120mg m/r tablet	Loratadine and pseudoephedrine only product in oral dose form
Loratadine+pseudoephedrine sulfate 5mg/120mg prolonged-release oral tablet	Loratadine and pseudoephedrine only product in oral dose form
Lordosis in hip disease	Lordosis deformity of spine due to disorder of hip region
Lordosis in skeletal dysplasia	Lordosis deformity of spine due to congenital skeletal dysplasia
Lovastatin 10mg m/r tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 10mg prolonged-release oral tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 20mg m/r tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 20mg prolonged-release oral tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 40mg m/r tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 40mg prolonged-release oral tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 60mg m/r tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Lovastatin 60mg prolonged-release oral tablet	Product containing only lovastatin in oral dose form (medicinal product form)
Low cervical cesarean section	Lower uterine segment caesarean section
Low cervical cesarean section	Lower uterine segment caesarean section
Low pressure hydrocephalus	Normal pressure hydrocephalus
Lower leg flap	Flap (substance)
Lower leg random pattern flap	Random pattern flap
Lower limb flap	Flap (substance)
Lower uterine segment cesarean delivery NEC	Lower uterine segment caesarean section
smeermiddel	Automotive lubricant
smeerolie	Automotive lubricating oil (substance)
Lucilia sericata	Phaenicia sericata
discographie lombaire	Discography with injection of contrast into intervertebral disc of lumbar spine (procedure)
Lumbar somatic dysfunction	Somatic dysfunction of lumbar region (finding)
Lumbar spine DXA scan	Dual energy X-ray absorptiometry of lumbar spine (procedure)
Lumbar spine DXA scan	Dual energy X-ray absorptiometry of lumbar spine (procedure)
Lumbar spine DXA scan T score	Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity)
Lumbar spine DXA scan T score	Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity)
Lumbar spine DXA scan Z score	Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity)
Lumbar spine DXA scan Z score	Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity)
Lumbar spine dual energy X-ray absorptiometry scan (procedure)	Dual energy X-ray absorptiometry of lumbar spine (procedure)
Lumbar spine dual energy X-ray photon absorptiometry scan T score	Dual energy X-ray photon absorptiometry lumbar spine scan T score (observable entity)
Lumbar spine dual energy X-ray photon absorptiometry scan Z score	Dual energy X-ray photon absorptiometry lumbar spine scan Z score (observable entity)
Lumbar spine operations NOS	Surgical procedure on lumbar spine (procedure)
Lung TNM finding	American Joint Committee on Cancer allowable value
Lupus erythematosus cell	Lupus erythematosus cell
Luteinizing hormone releasing factor	Gonadotropin releasing factor (substance)
Luteinizing hormone releasing factor preparation	Product containing gonadotropin releasing factor (product)
Lutropin alfa 75iu injection (pdr for recon)+solvent	Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)
Lutropin alfa 75iu injection (pdr for recon)+solvent	Product containing precisely lutropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)
Luy's nucleus (body structure)	Structure of subthalamic nucleus of Luy (body structure)
goitre lymphadénoïde	Hashimoto thyroiditis
Lymphadenopathy-associated virus, type II (LAV-II)	Human immunodeficiency virus type 2
Lymphangioma, no International Classification of Diseases for Oncology subtype	Benign lymphangioma
Lymphatic incision NOS	Incision of lymphatic system structure
Lymphatic incision NOS	Incision of lymphatic system structure
Lymphocystis disease virus group	Genus Lymphocystivirus (organism)
Lymphoid leukemia - category	Lymphoid leukaemia
Lymphoma morphology	Malignant lymphoma
Lymphoproliferative disease, no International Classification of Diseases for Oncology subtype	Lymphoproliferation of uncertain behavior (morphologic abnormality)
Lymphosarcoma cell leukemia	Lymphoid leukaemia
Lymphosarcoma cell leukemia	Lymphoid leukaemia
Lymphosarcoma of extranodal AND/OR solid organ site	Non-Hodgkin's lymphoma (clinical)
Lymphosarcoma of intra-abdominal lymph nodes	Mixed cell type lymphosarcoma of intra-abdominal lymph nodes
Lymphosarcoma of intrapelvic lymph nodes	Non-Hodgkin's lymphoma (clinical)
Lymphosarcoma of intrathoracic lymph nodes	Mixed cell type lymphosarcoma of intrathoracic lymph nodes
Lymphosarcoma of lymph nodes of axilla AND/OR upper limb	Non-Hodgkin's lymphoma (clinical)
Lymphosarcoma of lymph nodes of head, face AND/OR neck (disorder)	Non-Hodgkin's lymphoma (clinical)
Lymphosarcoma of lymph nodes of inguinal region AND/OR lower limb	Non-Hodgkin's lymphoma (clinical)
Lymphosarcoma of lymph nodes of multiple sites	Malignant lymphoma of lymph nodes (disorder)
Lymphosarcoma of spleen	Non-Hodgkin's lymphoma (clinical)
Lyophilized powder for conventional release liposomal suspension for injection	Lyophilized powder for conventional release suspension for injection (dose form)
allergie à la lypressine	Allergy to antidiuretic hormone
Lysis of adhesions of abdomen	Lysis of adhesions of peritoneum
Lückenschadel	Craniolacunia
M+nage E trois	Ménage à trois
stade M0	American Joint Committee on Cancer cM0 (qualifier value)
M1 (IV): Distant metastasis	American Joint Committee on Cancer cM1 (qualifier value)
M1 (IVB): Distant metastasis	American Joint Committee on Cancer cM1 (qualifier value)
M1	American Joint Committee on Cancer cM1 (qualifier value)
M1: Distant metastasis [includes metastasis to ipsilateral supraclavicular lymph nodes]	American Joint Committee on Cancer cM1 (qualifier value)
M1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral)	American Joint Committee on Cancer cM1 (qualifier value)
M1a (III): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement	American Joint Committee on Cancer cM1a (qualifier value)
M1a (IIIA): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement without risk factors	American Joint Committee on Cancer cM1a (qualifier value)
M1a (IIIB): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with one risk factor	American Joint Committee on Cancer cM1a (qualifier value)
M1a (IIIC): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with two risk factors	American Joint Committee on Cancer cM1a (qualifier value)
M1a: Non-regional lymph node or pulmonary metastasis	American Joint Committee on Cancer cM1a (qualifier value)
M1a: non-regional lymph node metastasis	American Joint Committee on Cancer cM1a (qualifier value)
M1b (IV): All other metastatic sites	American Joint Committee on Cancer cM1b (qualifier value)
M1b (IVA): All other metastatic sites without risk factors	American Joint Committee on Cancer cM1b (qualifier value)
M1b (IVB): All other metastatic sites with one risk factor	American Joint Committee on Cancer cM1b (qualifier value)
M1b (IVC): All other metastatic sites with two risk factors	American Joint Committee on Cancer cM1b (qualifier value)
M1b: Bone(s)	American Joint Committee on Cancer cM1b (qualifier value)
M1b: Distant metastasis other than to non-regional lymph nodes and lungs	American Joint Committee on Cancer cM1b (qualifier value)
M1c: Other site(s)	cM1c
MV	megavolt (qualifier value)
MYH9-gerelateerde macrotrombocytopenie	MYH9 related disease

Start Previous Page 71 of 155 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001156010	REPLACED BY association reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001157018	REPLACED BY association reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
7237811000172118	referentieset voor associaties betreffende vervangende concepten	nl	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Belgian module (core metadata concept)